Sessions & Syllabus
For your convenience, printer-friendly copies of the session slides are available to view and download approximately 1 week prior to the event. Materials will not be provided on-site. Review session slides prior to attending the program and come equipped with questions for our faculty. At this time no slides are available, please check back soon.
| Pre-Conference Day, Thursday, November 15, 2012 | Jump to:
Track 1
Track 2 |
|
|
pmiCME Updates Track 1 |
|
To date, the following organizations have provided educational grants in support of pmiCME Updates
Track 1: Bristol-Myers Squibb and AstraZeneca Pharmaceuticals LP, Alliance Partners, Forest Research Institute, a subsidiary of Forest Laboratories, Inc., and Ironwood Pharmaceuticals, Kowa Pharmaceuticals America, Inc. and Lilly USA, LLC and Novo Nordisk Inc.
|
| 8:00 AM-9:30 AM |
Session Information to Come
|
| 9:30 AM-9:45 AM |
AM Break
|
| 9:45 AM-11:00 AM |
Assessing Statin Therapy: What are Their Differences?
Learning Objectives:
- Recognize statin drug interactions and select appropriate therapies that will not carry an increased risk of adverse events.
- Apply evidence-based clinical study data into practice that demonstrates statins’ ability to modify both LDL-C and HDL-C to optimize drug selection.
- Evaluate the available safety data concerning statins, proteinuria, hyperglycemia, and dose reduction requirements in patients with kidney failure and apply this knowledge to therapeutic risk/benefit analysis.
|
| 11:00 AM-12:15 PM |
Targeting the Kidney in Managing the Patient with Type 2 Diabetes: A New Approach
Learning Objectives:
- Discuss the role of the kidney in glucose homeostasis
- Describe the contribution of the kidney to the sustained elevated glucose levels observed in individuals with uncontrolled type 2 diabetes.
- Explain the mechanism of action of therapies that act through the kidney to reduce hyperglycemia in type 2 diabetes
- Assess clinical efficacy and safety data, and identify the potential place of therapies that target the kidney in the management of type 2 diabetes
|
| 12:15 PM-1:00 PM |
Lunch Break
|
| 1:00 PM-2:15 PM |
Enhancing Patient Diagnosis and Management of COPD: A Case-Based Review
Learning Objectives:
- Prevent COPD exacerbations by recognizing the clinical factors that put patients at risk by improving early recognition and intervention
- Stratify COPD severity and develop individualized treatment plans on the basis of spirometry results
- Tailor both initial and maintenance therapies for COPD according to the standards set by evidence-based guidelines
|
| 2:15 PM-2:30 PM |
PM Break
|
| 2:30 PM-3:45 PM |
Under Pressure: The Need to Expedite IBS Diagnosis and Treatment in Primary Care
Learning Objectives:
- Diagnose IBS based upon symptoms that may be shared with other functional gastrointestinal disorders or organic diseases
- Compare and contrast the efficacy and safety of available pharmacologic and nonpharmacologic treatment options for IBS
- Apply appropriate and comprehensive treatment strategies to enhance the care of patients with IBS
|
| 3:45 PM-5:15 PM |
Insulin 101: An Introduction to Insulin Therapy in the 21st Century
Learning Objectives:
- Calculate appropriate insulin doses for initiating basal and basal-prandial insulin regimens in T2DM
- Demonstrate best practices in insulin injection and SMBG techniques to improve treatment adherence and potentially impact patient outcomes
- Apply pattern recognition to SMBG data to appropriately titrate insulin doses and adjust insulin regimens to specific patient needs
- Summarize the efficacy and safety findings from clinical trials of investigational insulins and the combination of incretin-based therapies with insulin
|
|
pmiCME Updates Track 2 |
|
To date, the following organizations have provided educational grants in support of pmiCME Updates
Track 2: Sanofi Biosurgery and sanofi-aventis U.S. Inc.
|
| 8:00 AM-9:15 AM |
A Patient-Centered Approach to the Management of Depression: Achieving and Maintaining Remission in the Primary Care Setting
Learning Objectives:
- Outline the social and economic impact of depression and related comorbidities in the United States.
- Define optimal outcomes in major depressive disorder as compared to suboptimal response and examine the impact of failing to achieve remission on patient outcomes.
- Evaluate measurement-based care, specifically the APA guidelines, and strategies for implementation in practice to address unmet clinical needs of patients with depression when initial antidepressants are insufficient.
- Using a case-based approach, apply clinical data and guideline recommendations to the clinical care of patients suffering from depression and formulate appropriate and effective treatment plans.
|
| 9:15 AM-9:30 AM |
AM Break
|
| 9:30 AM-10:45 AM |
Type 2 Diabetes - Role of Insulin-Based Therapy
Learning Objectives:
- Describe the pathophysiology of T2DM and its practical implications for multi-organ disease mandating early recognition and treatment
- Conduct an initial and ongoing assessment of A1C, fasting blood glucose, and postprandial blood glucose to achieve tight glycemic control, with appropriate referral when necessary
- Evaluate the mechanisms and clinical profiles of insulin formulations, addressing dosing regimen, patient age, ethnicity, and other determinants of individualized care
- Collaborate with endocrinologists, cardiologists, nurse practitioners, dietitians, diabetes educators, and other care providers to formulate and implement a comprehensive treatment that includes pharmacologic as well as lifestyle interventions
- Educate patients on the causes, symptoms, and risks associated with hypoglycemia and implement new models of care to overcome patient and system barriers to therapeutic regimen adherence
Richard Sadovsky, MD , Associate Professor of Family Medicine,
SUNY Downstate Medical Center,
New York, NY
Jeff Unger, MD, FAAFP , Director, Metabolic Studies,
Catalina Research Institute,
Chino, CA
|
| 10:45 AM-12:00 PM |
Session Information to Come
|
| 12:00 PM-12:45 PM |
Lunch Break
|
| 12:45 PM-2:15 PM |
Evidence Based Strategies to Improve Glycemic Control in Type 2 Diabetes
Learning Objectives:
- Apply current data from clinical trials for A1C goal setting and individualization of treatment
- Recognize the importance of timely initiation of drug therapy including the early insulin initiation in reducing the complications of type 2 diabetes
- Describe interdisciplinary team and collaborative care approaches that can improve clinical outcomes
- Identify and implement strategies for overcoming the barriers to insulin initiation and medication adherence
Luigi F. Meneghini, MD, MBA
( Read Bio)
, Professor of Clinical Medicine,
Director, Kosow Diabetes Treatment Center,
Diabetes Research Institute,
Division of Endocrinology, Diabetes & Metabolism,
University of Miami School of Medicine,
Miami, FL Silvio E. Inzucchi, MD
( Read Bio)
, Professor of Medicine,
Yale University School of Medicine,
New Haven, CT, , Director,
Yale Diabetes Center,
New Haven, CT |
| 2:15 PM-2:30 PM |
PM Break
|
| 2:30 PM-3:45 PM |
Defining the Role of Intra-Articular Injections in the Management of Knee Osteoarthritis Pain
Learning Objectives:
- Explain the pathophysiology of OA of the knee and how current treatment options may affect various pain pathways and/or the potential for disease modification
- Consider individual patient and treatment characteristics (e.g., comorbidities, stage of disease, level of pain, drug tolerability, previous response to treatment) when initiating a multi-modal treatment plan for patients with knee OA
- Describe the individual clinical and patient characteristics that guide the selection of intraarticular corticosteroid and HA injection therapy
- Compare and contrast the clinical utility of intra-articular corticosteroids and/or HA injection therapy
|
| 3:45 PM-5:15 PM |
Session Information to Come
|
| Friday, November 16, 2012 |
|
| 9:15 AM-11:45 AM |
Symposia |
| 9:15 AM-11:45 AM |
|
| 1:30 PM-5:45 PM |
Symposia |
| 1:30 PM-5:45 PM |
|
| Saturday, November 17, 2012 |
|
| 9:30 AM-11:45 AM |
Symposia |
| 9:30 AM-11:45 AM |
|
| 1:30 PM-5:45 PM |
Symposia |
| 1:30 PM-5:45 PM |
|
| Sunday, November 18, 2012 |
|
